Endocrine

, Volume 37, Issue 1, pp 187–193 | Cite as

Inhibitory effect of valproic acid on ovarian androgen biosynthesis in rat theca-interstitial cells

  • Senait Fisseha
  • Roberto Towns
  • Miyuki Harada
  • Helle Peegel
  • K. M. J. Menon
Original Article

Abstract

The objective of the study was to evaluate the effect of valproic acid (VPA) on ovarian androgen biosynthesis in primary cultures of theca-interstitial (T-I) cells isolated from rat ovaries. Ovarian T-I cells were cultured with VPA in the presence or absence of hCG. VPA did not increase basal or hCG-stimulated androgen synthesis when added to primary cultures of T-I cells. However, the addition of VPA caused a marked concentration-dependent inhibitory effect on hCG-stimulated androstendione synthesis. Treatment of T-I cells with 8-Bromo-cAMP resulted in a marked increase in the production of androstenedione, and VPA inhibited this stimulatory effect, suggesting that the mechanism of VPA’s inhibitory effect on androstenedione production occurs at a step after second messenger activation. Treatment of T-I cells with hCG resulted in a significant increase in the mRNA expression of steroidogenic enzymes CYP17A1 and 17β-hydroxysteroid dehydrogenase. Addition of VPA sharply blunted the stimulatory effect of hCG, reducing the mRNA expression of the steroidogenic enzymes to basal levels. In conclusion, VPA exerts an inhibitory effect on hCG-stimulated androgen synthesis in rat T-I cells.

Keywords

Theca-interstitial cells Androgen synthesis hCG Steroidogenesis Androstenedione Valproic acid PCOS 

References

  1. 1.
    M.F. Reynolds, E.C. Sisk, N.L. Rasgon, Curr. Med. Chem. 14, 2799–2812 (2007)CrossRefPubMedGoogle Scholar
  2. 2.
    D.C. Lagace, M.W. Nachtigal, Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 587–594 (2003)CrossRefPubMedGoogle Scholar
  3. 3.
    A.G. Herzog, M.M. Seibel, D. Schomer, J. Vaitukaitis, N. Geschwind, Neurology 34, 1389–1393 (1984)PubMedGoogle Scholar
  4. 4.
    R. Meo, L. Bilo, Drugs 63, 1185–1227 (2003)CrossRefPubMedGoogle Scholar
  5. 5.
    J. Isojarvi, T. Laatikainen, A. Pakarinen, K. Juntunen, V. Myllyla, N. Engl. J. Med. 329, 1383–1388 (1993)CrossRefPubMedGoogle Scholar
  6. 6.
    L. Bilo, R. Meo, Gynecol. Endocrinol. 24, 562–570 (2008)CrossRefPubMedGoogle Scholar
  7. 7.
    J.R. Wood, V.L. Nelson-DeGrave, E. Jansen, J.M. McAllister, S. Mosselman, J.F. Strauss, Physiol. Genomics 20, 233–243 (2005)PubMedGoogle Scholar
  8. 8.
    V.L. Nelson-DeGrave, J.K. Wickenheisser, J.E. Cockrell, J.R. Wood, R.S. Legro, J.F. Strauss, J.M. McAllister, Endocrinology 145, 799–808 (2004)CrossRefPubMedGoogle Scholar
  9. 9.
    E. Tauboll, L. Roste, S. Svalheim, L. Gjerstad, Seizure 17, 120–126 (2008)CrossRefPubMedGoogle Scholar
  10. 10.
    N. Jacobsen, B. Halling-Sorensen, F. Birlvea, Toxicol. In Vitro 22, 146–153 (2008)CrossRefPubMedGoogle Scholar
  11. 11.
    C.E. Fluck, D.C. Yaworsky, W.L. Miller, Epilepsia 46, 444–448 (2005)CrossRefPubMedGoogle Scholar
  12. 12.
    M. Ferin, M. Morrell, E. Xiao, L. Kochan, F. Qian, T. Wright, M. Sauer, J. Clin. Endocrinol. Metab. 88, 2908–2915 (2003)CrossRefPubMedGoogle Scholar
  13. 13.
    L. Roste, E. Tauboll, J. Isojarvi, A.J. Pakarinen, I. Huhtaniemi, M. Knip, Reprod. Toxicol. 16, 767–773 (2002)CrossRefGoogle Scholar
  14. 14.
    K.M.J. Menon, U.M. Munshi, C.L. Clouser, A.K. Nair, Biol. Reprod. 70, 861–866 (2004)CrossRefPubMedGoogle Scholar
  15. 15.
    R. Towns, K.M.J. Menon, Mol. Cell. Endocrinol. 245, 23–30 (2005)CrossRefPubMedGoogle Scholar
  16. 16.
    G. Murialdo, C.A. Galimberti, F. Magri, P. Sampaolo, F. Copello, M.V. Gianelli, E. Gazzerro, A. Rollero, C. Deagatone, R. Manni, E. Ferrari, A. Polleri, A. Tartara, J. Endocrinol. Invest. 20, 519–526 (1997)PubMedGoogle Scholar
  17. 17.
    B. Bruguerolle, G. Jadot, M. Valli, P. Bouyard, C R Seances Soc. Biol. Fil. 176, 359–363 (1982)PubMedGoogle Scholar
  18. 18.
    E.L. Gregoraszczuk, A.K. Wojtowicz, E. Tauboll, E. Ropstad, Seizure 9, 480–485 (2000)CrossRefPubMedGoogle Scholar
  19. 19.
    A.K. Death, K.C. McGrath, D.J. Handelsman, Steroids 70, 946–953 (2005)CrossRefPubMedGoogle Scholar
  20. 20.
    H.E. Scharfman, M. Kim, T.M. Hintz, N.J. MacLusky, Ann. Neurol. 64, 687–697 (2008)CrossRefPubMedGoogle Scholar
  21. 21.
    R. Meo, L. Bilo, C. Nappi, A.P. Tommaselli, R. Valentino, C. Nocerino, S. Striano, G.A. Buscaino, Seizure 2, 241–252 (1993)CrossRefPubMedGoogle Scholar
  22. 22.
    V. Pylvanen, A. Pakarinen, M. Knip, J. Isojarvi, Epilepsia 47, 1460–1464 (2006)CrossRefPubMedGoogle Scholar
  23. 23.
    C. Le Goascogne, N. Sananes, M. Gouezou, S. Takemori, S. Kominami, E.E. Baulieu, P.J. Robel, J. Reprod. Fertil. 93, 609–622 (1991)CrossRefPubMedGoogle Scholar
  24. 24.
    L.M. Perkins, A.H. Payne, Endocrinology 123, 2675–2682 (1988)CrossRefPubMedGoogle Scholar
  25. 25.
    A. Verrotti, F. Basciani, M. De Simone, D. Trotta, G. Morgese, F. Chiarelli, J. Child Neurol. 17, 265–268 (2002)CrossRefPubMedGoogle Scholar
  26. 26.
    Q. Wu, S. Sucheta, S. Azhar, K.M.J. Menon, Endocrinology 144, 2437–2445 (2003)CrossRefPubMedGoogle Scholar
  27. 27.
    A. Payne, J. Downing, K.L. Wong, Endocrinology 106, 1424–1429 (1980)CrossRefPubMedGoogle Scholar
  28. 28.
    K. Giles, A. Myers, Nature 206, 93 (1965)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Senait Fisseha
    • 1
    • 2
  • Roberto Towns
    • 1
    • 2
  • Miyuki Harada
    • 1
    • 2
  • Helle Peegel
    • 1
    • 2
  • K. M. J. Menon
    • 1
    • 2
    • 3
  1. 1.Department of Obstetrics/GynecologyUniversity of Michigan Medical SchoolAnn ArborUSA
  2. 2.Department of Biological ChemistryUniversity of Michigan Medical SchoolAnn ArborUSA
  3. 3.University of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations